payment for machinery - 59,153,123.00 Advance payment for license 9,832,500.12 9,832,500.12 Other Non- current assets 992,969.97 3,406,847.89 Long-term insurance 12,623,705.60 2,255,897.95 Total Non
government has policies to help the cost of living of people at the grassroots level, it focuses on spending of the essential consumer products only. Products of the Company: For Medical Devices; There is
) (48.76%) 1 - Construction 556.10 343.54 212.56 61.87% 2 - Testing and Inspection 19.20 15.83 3.37 21.29% 3 Cost of sales and services (687.57) (494.89) 192.68 38.93% Gross Profit 80.26 56.52 23.74 42.00
12,410.0 11,622.2 (787.8) (6.3%) Total Cost 5,001.5 4,631.8 (369.8) (7.4%) Gross Profit/2 6,475.5 6,232.8 (242.8) (3.7%) Net Profit 3,266.4 2,906.8 (359.6) (11.0%) Normalized Total Revenue/3 11,836.1
to refinance existing bank loan to reduce finance cost. The Management expected the Bond to be offered to investor within August 2017. EGM approved par split from 5 Baht to 1 Baht and the Company
(mn) 3Q 2016 2Q 2017 3Q 2017 QoQ (%) YoY (%) Operating Revenue 172 199 262 31.8% 52.1% Cost of sales 79 87 106 21.7% 34.8% Gross profit 94 112 156 39.7% 66.7% Selling, General & Administrative Expense
September, 2017, respectively as per the planned schedule 2 In Q32017, the Company issued the debentures for the first time to refinance existing bank loan to reduce finance cost in the amount of Baht 4,000
shareholder at Annual General Meeting resolved to approve the cash dividend payment from the operating results of 2H 2017 at THB 0.018 per share (a total of THB 62mn). The total dividend payment from 2017
) Cost of sales and service 953.9 1,323.0 1,015.4 (369.1) (27.9) (61.5) (6.1) Administrative expenses 96.6 143.2 94.0 (46.6) (32.5) 2.6 2.8 Income tax expenses 26.2 46.7 33.4 (20.5) (43.9) (7.2) (21.6
budget risk especially for the High Cost Care (AdjRW> 2). Moreover, The Company expects to receive an improved payment term from Social Security Office. - Opening of Kasemrad Hospital International